BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/25/2026 8:51:32 AM | Browse: 109 | Download: 145
 |
Received |
|
2025-10-17 11:47 |
|
Peer-Review Started |
|
2025-10-17 11:47 |
|
First Decision by Editorial Office Director |
|
2025-10-29 08:30 |
|
Return for Revision |
|
2025-10-29 08:30 |
|
Revised |
|
2025-11-23 04:31 |
|
Publication Fee Transferred |
|
2025-11-28 03:16 |
|
Second Decision by Editor |
|
2026-01-19 02:45 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-01-26 11:49 |
|
Articles in Press |
|
2026-01-26 11:49 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-03-18 06:43 |
|
Publish the Manuscript Online |
|
2026-03-25 08:45 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Basic Study |
| Article Title |
Exosomes of adipose-derived mesenchymal stem cells loaded with globular adiponectin improve islet function for type 2 diabetes
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
An-Ran Wang, Yu-Yang Zhang, Yi-Jun Liu, Li-Nan Ren, Qi-Hui Yan, Kai-Fang Wang and Yan Wang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Basic Research Program of Shanxi Province |
20210302123241 |
|
| Corresponding Author |
Yan Wang, Department of Endocrinology, First Hospital of Shanxi Medical University, No. 85 Jiefang South Road, Taiyuan 030001, Shanxi Province, China. wysdyy@126.com |
| Key Words |
Adipose-derived mesenchymal stem cells; Exosomes; Type 2 diabetes mellitus; Insulin sensitivity; Islet function |
| Core Tip |
Researchers have developed a promising new approach to treat type 2 diabetes using exosomes (Exos) derived from adipose-derived mesenchymal stem cells loaded with globular adiponectin (gAd) - referred to as gAd-Exo. The combination of gAd and Exo produced a significant synergistic effect. In a diabetic rat model, gAd-Exo significantly lowered blood glucose, reduced pancreatic islet cell death, and improved insulin sensitivity. It also helped restore the structure and function of pancreatic islets. Mechanistically, gAd-Exo activated key metabolic pathway - AMP-activated protein kinase/acetyl-CoA carboxylase - which are crucial for energy metabolism and cell survival. This study highlights the potential of Exo-mediated delivery to enhance the efficacy of therapeutic molecules like gAd, offering a targeted and sustained treatment strategy for type 2 diabetes. |
| Publish Date |
2026-03-25 08:45 |
| Citation |
Wang AR, Zhang YY, Liu YJ, Ren LN, Yan QH, Wang KF, Wang Y. Exosomes of adipose-derived mesenchymal stem cells loaded with globular adiponectin improve islet function for type 2 diabetes. World J Stem Cells 2026; 18(3): 115363 |
| URL |
https://www.wjgnet.com/1948-0210/full/v18/i3/115363.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v18.i3.115363 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
